Barclays Has Lowered Expectations for Allstate (NYSE:ALL) Stock Price

Allstate (NYSE:ALL) had its price objective cut by equities researchers at Barclays from $187.00 to $183.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has an “underweight” rating on the insurance provider’s stock. Barclays‘s target price suggests a potential downside of 1.57% from the company’s previous close.

ALL has been the topic of a number of other research reports. JPMorgan Chase & Co. raised their target price on shares of Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a research note on Thursday, October 10th. Raymond James lifted their target price on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. UBS Group increased their price target on Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Wells Fargo & Company boosted their price objective on Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 5th. Finally, Piper Sandler increased their target price on Allstate from $206.00 to $244.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Allstate presently has an average rating of “Moderate Buy” and a consensus price target of $216.94.

Allstate Stock Performance

Shares of NYSE ALL opened at $185.91 on Monday. Allstate has a 12-month low of $148.23 and a 12-month high of $209.88. The firm has a market capitalization of $49.23 billion, a price-to-earnings ratio of 12.04, a price-to-earnings-growth ratio of 1.70 and a beta of 0.52. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The firm has a 50 day moving average of $195.77 and a 200 day moving average of $185.14.

Allstate (NYSE:ALL) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. During the same period in the prior year, the business posted $0.81 EPS. Allstate’s revenue was up 14.7% on a year-over-year basis. On average, research analysts anticipate that Allstate will post 16.26 earnings per share for the current year.

Institutional Trading of Allstate

A number of institutional investors have recently bought and sold shares of the stock. Boltwood Capital Management boosted its stake in shares of Allstate by 10.5% during the 4th quarter. Boltwood Capital Management now owns 7,710 shares of the insurance provider’s stock worth $1,486,000 after purchasing an additional 730 shares during the period. Nordea Investment Management AB boosted its position in shares of Allstate by 1.2% during the fourth quarter. Nordea Investment Management AB now owns 54,086 shares of the insurance provider’s stock valued at $10,397,000 after buying an additional 631 shares during the period. GAMMA Investing LLC grew its stake in shares of Allstate by 27.2% during the fourth quarter. GAMMA Investing LLC now owns 5,070 shares of the insurance provider’s stock valued at $977,000 after buying an additional 1,084 shares during the last quarter. Versant Capital Management Inc increased its stake in Allstate by 146.2% in the fourth quarter. Versant Capital Management Inc now owns 384 shares of the insurance provider’s stock worth $74,000 after purchasing an additional 228 shares during the period. Finally, JPMorgan Chase & Co. lifted its holdings in Allstate by 5.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 577,934 shares of the insurance provider’s stock valued at $109,605,000 after buying an additional 28,584 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.